Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
South African Press Association - November 11, 2009
"We have always been concerned on whether it is correct to wait with treatment until a person's CD4 count has dropped to 200 [cells per microlitre]. We believe it might contribute to a higher mortality rate by delaying treatment," Sama chairperson Norman Mabasa said in a statement on Wednesday.
The CD4 count is used to measure the strength of a person's immune system.
Health Minister Aaron Motsoaledi said on Tuesday that in the 11 years from 1997 to 2008, the rate of death doubled in South Africa.
In 2007, the total number of deaths -- from all causes -- registered in South Africa was 573 408; in 2008 this figure had leapt to 756 062.
Motsoaledi pinned the blame for the current scale of the pandemic squarely on the denialist health policies pursued by former president Thabo Mbeki's government.
Mabasa said the treatment threshold of 200 should be lifted to a CD4 count of between 300 and 350, which would be in line with global trends.
"This must apply to both public and private sector, as HIV/Aids does not discriminate. We are cognisant that this step will result in more people requiring treatment and thus there would be financial implications, and government must be committed to it."
091111
SA091104
Copyright © 2009 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .